Literature DB >> 12205425

Bone morphogenetic protein gene therapy.

Tord D Alden1, Peter Varady, David F Kallmes, John A Jane, Gregory A Helm.   

Abstract

STUDY
DESIGN: A retrospective analysis of previous BMP gene therapy and general gene therapy publications.
OBJECTIVE: To present the potential role of BMP gene therapy for the induction of osteogenesis and spinal fusion. SUMMARY OF BACKGROUND DATA: A variety of viral and non-viral techniques have been utilized to insert foreign transgenes into cells, both in vivo and in vitro. These techniques are now being used to transduce cells with a BMP gene to express significant amounts of BMP. This secreted BMP can subsequently stimulate osteogenesis in a variety of locations, including in the paraspinal regions.
METHODS: A retrospective analysis of the literature.
RESULTS: Direct and ex vivo BMP gene therapy has been shown to successfully promote bone healing and regeneration in a variety of animal models. Long-term and regulated transgene expression are clear advantages of BMP gene delivery, compared to direct BMP application. To date, BMP gene delivery with adenoviral vectors have been the most effective approach for stimulating bone induction in vivo.
CONCLUSIONS: Although BMP gene therapy techniques have significant potential for the treatment of spine pathology, further preclinical and clinical research and development are required before this technology will have direct clinical applications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205425     DOI: 10.1097/00007632-200208151-00016

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

Review 1.  New Strategies in Enhancing Spinal Fusion.

Authors:  Yoshihiro Katsuura; Karim Shafi; Chelsie Jacques; Sohrab Virk; Sravisht Iyer; Matthew Cunningham
Journal:  HSS J       Date:  2020-02-02

2.  BMP gene delivery for alveolar bone engineering at dental implant defects.

Authors:  Courtney A Dunn; Qiming Jin; Mario Taba; Renny T Franceschi; R Bruce Rutherford; William V Giannobile
Journal:  Mol Ther       Date:  2005-02       Impact factor: 11.454

3.  Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair.

Authors:  F Alaee; O Sugiyama; M S Virk; H Tang; H Drissi; A C Lichtler; J R Lieberman
Journal:  Gene Ther       Date:  2013-11-28       Impact factor: 5.250

4.  Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor.

Authors:  Jin-jing Wang; Feng Ye; Li-jia Cheng; Yu-jun Shi; Ji Bao; Huai-qiang Sun; Wei Wang; Peng Zhang; Hong Bu
Journal:  J Zhejiang Univ Sci B       Date:  2009-05       Impact factor: 3.066

5.  Effects of Roughly Focused Extracorporeal Shock Waves Therapy on the Expressions of Bone Morphogenetic Protein-2 and Osteoprotegerin in Osteoporotic Fracture in Rats.

Authors:  Hai-Ming Huang; Xiao-Lin Li; Shu-Qiang Tu; Xiao-Feng Chen; Chang-Chun Lu; Liang-Hua Jiang
Journal:  Chin Med J (Engl)       Date:  2016-11-05       Impact factor: 2.628

6.  Construction and characterization of a recombinant human adenovirus vector expressing bone morphogenetic protein 2.

Authors:  Zheng Zhang; Guoxian Wang; Chen Li; Danping Liu
Journal:  Exp Ther Med       Date:  2013-06-17       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.